Table 1.

Clinical and pathological features

Parameter	Overall, no. (%)
Number of Patients	3,557
Age (years), mean (SD)	59.6 (7.1)
BMI, mean (SD)	28.4 (4.7)
Race (%)
Caucasian	2,688 (75)
African American	531 (15)
Asian	130 (4)
Hispanic and Other	49 (1)
Year of surgery (%)
2003–2005	379 (11)
2006–2008	1,299 (37)
2009–2011	1,155 (32)
2012–2015	724 (20)
Biopsy Gleason Sum (%)
6	1,670 (47)
7	1,489 (42)
8	214 (6)
9	105 (3)
10	2 (0.06)
Pathologic Gleason Sum (%)
6	1,088 (31)
7	2,213 (62)
8	131 (4)
9	123 (3)
Clinical Stage (%)
cT1a / cT1b	12 (0.3)
cT1c	2,460 (69)
cT2a	633 (18)
cT2b	228 (6)
cT2c	76 (2)
cT3a	24 (0.7)
cT3b	4 (0.1)
Pathologic Stage (%)
pT2a	320 (9)
pT2b	304 (9)
pT2c	2,009 (56)
pT3a	728 (20)
pT3b	193 (5)
PSA, ng/ml, median (IQR)	5.2 (4.1–7.2)